{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:41:45Z","timestamp":1758814905188},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,4,1]]},"DOI":"10.1093\/ndt\/16.4.725","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:52:52Z","timestamp":1027723972000},"page":"725-734","source":"Crossref","is-referenced-by-count":20,"title":["Selective blockade of vasopressin V2 receptors reveals significant V2\u2010mediated water reabsorption in Brattleboro rats with diabetes insipidus"],"prefix":"10.1093","volume":"16","author":[{"given":"Brigitte","family":"Pouzet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Serradeil\u2010Le Gal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Bouby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Pierre","family":"Maffrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Le Fur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Bankir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,4]]},"reference":[{"key":"key\n\t\t\t\t20180110065227_R1","doi-asserted-by":"crossref","unstructured":"Schmale H, Ivell R, Breindl M, Darmer D, Richter D. The mutant vasopressin gene from diabetes insipidus (Brattleboro) rats is transcribed but the message is not efficiently translated. EMBO J1984; 3: 3289\u20133293","DOI":"10.1002\/j.1460-2075.1984.tb02291.x"},{"key":"key\n\t\t\t\t20180110065227_R2","doi-asserted-by":"crossref","unstructured":"Valtin H. Genetic models of diabetes insipidus. In: E.E. Windhager, ed. Handbook of Physiology. Oxford University Press, New York, 1992; 1281\u20131315","DOI":"10.1002\/cphy.cp080228"},{"key":"key\n\t\t\t\t20180110065227_R3","unstructured":"Kinter LB, Ilson BE, Caltabianol S et al. Antidiuretic hormone antagonism in humans: are there predictors? In: Jard S, Jamison R, ed. Vasopressin. INSERM\/John Libbey Eurotext Ltd, Paris, London, 1991; 321\u2013329"},{"key":"key\n\t\t\t\t20180110065227_R4","doi-asserted-by":"crossref","unstructured":"Yamamura Y, Ogawa H, Yamashita H et al. Characterization of a novel aquaretic agent, OPC\u201031260, as an orally effective, non\u2010peptide vasopressin V2 receptor antagonist. Br J Pharmacol1992; 105: 787\u2013791","DOI":"10.1111\/j.1476-5381.1992.tb09058.x"},{"key":"key\n\t\t\t\t20180110065227_R5","unstructured":"Ohnishi A, Orita Y, Takagi N et al. Aquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men. J Pharmacol Exp Ther1995; 272: 546\u2013551"},{"key":"key\n\t\t\t\t20180110065227_R6","doi-asserted-by":"crossref","unstructured":"Shimizu K. Aquaretic effects of the nonpeptide V2 antagonist OPC\u201021260 in hydropenic humans. Kidney Int1995; 48: 220\u2013226","DOI":"10.1038\/ki.1995.287"},{"key":"key\n\t\t\t\t20180110065227_R7","doi-asserted-by":"crossref","unstructured":"Serradeil\u2010Le\u2010Gal C, Lacour C, Valette G et al. Charaterization of SR 121463A, a highly potent and selective orally active vasopressin V2 receptor antagonist. J Clin Invest1996; 98: 2729\u20132738","DOI":"10.1172\/JCI119098"},{"key":"key\n\t\t\t\t20180110065227_R8","doi-asserted-by":"crossref","unstructured":"Albright JD, Reich MF, Delos Santos EG et al. 5\u2010Fluoro\u20102\u2010methyl\u2010N\u2010[4\u2010(5H\u2010pyrrolo[2,1\u2010c]\u2010[1,4]benzodiazepin\u201010(11H)\u2010ylcarbonyl)\u20103\u2010chlorophenyl]benzamide (VPA\u2010985): an orally active arginine vasopressin antagonist with selectivity for V2 receptors. J Med Chem1998; 41: 2442\u20132444","DOI":"10.1021\/jm980179c"},{"key":"key\n\t\t\t\t20180110065227_R9","unstructured":"Yamamura Y, Nakamura S, Itoh S et al. OPC\u201041061, a highly potent human vasopressin V2\u2010receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther1998; 287: 860\u2013867"},{"key":"key\n\t\t\t\t20180110065227_R10","doi-asserted-by":"crossref","unstructured":"Bouby N, Ahloulay M, Nsegbe E, D\u00e9chaux M, Schmitt F, Bankir L. Vasopressin increases GFR in conscious rats through its antidiuretic action. J Am Soc Nephrol1996; 7: 842\u2013851","DOI":"10.1681\/ASN.V76842"},{"key":"key\n\t\t\t\t20180110065227_R11","doi-asserted-by":"crossref","unstructured":"Lyness J, Robinson AG, Sheridan MN, Gash DM. Antidiuretic effects of oxytocin in the Brattleboro rat. Experientia1985; 41: 1444\u20131446","DOI":"10.1007\/BF01950026"},{"key":"key\n\t\t\t\t20180110065227_R12","doi-asserted-by":"crossref","unstructured":"Levitin H, Goodman A, Pigeon G, Epstein FH. Composition of the renal medulla during water diuresis. J Clin Invest1962; 41: 1145\u20131151","DOI":"10.1172\/JCI104567"},{"key":"key\n\t\t\t\t20180110065227_R13","doi-asserted-by":"crossref","unstructured":"Atherton JC, green R, Thomas S, Wood JA. Time course of changes in renal tissue and urinary composition after cessation of constant infusion of lysine vasopressin in the conscious, hydrated rat. J Physiol (Lond)1972; 222: 583\u2013595","DOI":"10.1113\/jphysiol.1972.sp009816"},{"key":"key\n\t\t\t\t20180110065227_R14","doi-asserted-by":"crossref","unstructured":"Bouby N, Trinh\u2010Trang\u2010Tan MM, Bankir L. Stimulation of magnesium and calcium tubular reabsorption by antidiuretic hormone in conscious rats. Study in Brattleboro rats with hereditary hypothalamic diabetes insipidus. Pflugers Arch1984; 402: 458\u2013464","DOI":"10.1007\/BF00583948"},{"key":"key\n\t\t\t\t20180110065227_R15","doi-asserted-by":"crossref","unstructured":"Bankir L, Kriz W. Adaptation of the kidney to protein intake and to urine concentrating activity: similar consequences in health and disease (Editorial Review). Kidney Int1995; 47: 7\u201324","DOI":"10.1038\/ki.1995.2"},{"key":"key\n\t\t\t\t20180110065227_R16","doi-asserted-by":"crossref","unstructured":"Clements JA, Funder JW. Arginine vasopressin (AVP) and AVP\u2010like immunoreactivity in peripheral tissues. Endocr Rev1986; 7: 449\u2013460","DOI":"10.1210\/edrv-7-4-449"},{"key":"key\n\t\t\t\t20180110065227_R17","doi-asserted-by":"crossref","unstructured":"Andersen LJ, Andersen JL, Sch\u00fctten HJ, Warberg J, Bie P. Antidiuretic effect of subnormal levels of arginine vasopressin in normal humans. Am J Physiol1990; 259 (Regulatory Integrative Comp. Physiol. 28): R53\u201360","DOI":"10.1152\/ajpregu.1990.259.1.R53"},{"key":"key\n\t\t\t\t20180110065227_R18","doi-asserted-by":"crossref","unstructured":"Zerbe RL, Robertson GL. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. N Engl J Med1981; 305: 1539\u20131546","DOI":"10.1056\/NEJM198112243052601"},{"key":"key\n\t\t\t\t20180110065227_R19","doi-asserted-by":"crossref","unstructured":"Vierling AF, Little JB, Radford EP Jr. Antidiuretic hormone bio\u2010assay in rats with hereditary hypothalamic diabetes insipidus (Brattleboro strain). Endocrinology1967; 80: 211\u2013214","DOI":"10.1210\/endo-80-1-211"},{"key":"key\n\t\t\t\t20180110065227_R20","doi-asserted-by":"crossref","unstructured":"Costa T, Herz A. Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP\u2010binding proteins. Proc Natl Acad Sci USA1989; 86: 7321\u20137325","DOI":"10.1073\/pnas.86.19.7321"},{"key":"key\n\t\t\t\t20180110065227_R21","doi-asserted-by":"crossref","unstructured":"Lefkowitz RJ, Cotecchia S, Samama P, Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci1993; 14: 303\u2013307","DOI":"10.1016\/0165-6147(93)90048-O"},{"key":"key\n\t\t\t\t20180110065227_R22","doi-asserted-by":"crossref","unstructured":"Morin D, Cotte N, Balestre MN et al. The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities. FEBS Lett1998; 441: 470\u2013475","DOI":"10.1016\/S0014-5793(98)01585-3"},{"key":"key\n\t\t\t\t20180110065227_R23","doi-asserted-by":"crossref","unstructured":"Valtin H. Hereditary hypothalamic diabetes insipidus in rats (Brattleboro strain). A useful experimental model. Am J Med1967; 42: 814\u2013827","DOI":"10.1016\/0002-9343(67)90098-8"},{"key":"key\n\t\t\t\t20180110065227_R24","doi-asserted-by":"crossref","unstructured":"Edwards BR, LaRochelle FT Jr. Antidiuretic effect of endogenous oxytocin in dehydrated Brattleboro homozygous rats. Am J Physiol1984; 247: F453\u2013465","DOI":"10.1152\/ajprenal.1984.247.3.F453"},{"key":"key\n\t\t\t\t20180110065227_R25","doi-asserted-by":"crossref","unstructured":"Thibonnier M, Berti\u2010Mattera LN, Dulin N, Conarty DM, Mattera R. Signal transduction pathways of the human V1\u2010vascular, V2\u2010renal, V3\u2010pituitary vasopressin and oxytocin receptors. Prog Brain Res1998; 119: 147\u2013161","DOI":"10.1016\/S0079-6123(08)61568-X"},{"key":"key\n\t\t\t\t20180110065227_R26","doi-asserted-by":"crossref","unstructured":"Chou CL, DiGiovanni SR, Mejia R, Nielsen S, Knepper MA. Oxytocin as an antidiuretic hormone. I. Concentration dependence of action. Am J Physiol1995; 269: F70\u201377","DOI":"10.1152\/ajprenal.1995.269.1.F70"},{"key":"key\n\t\t\t\t20180110065227_R27","doi-asserted-by":"crossref","unstructured":"Chou CL, DiGiovanni SR, Luther A, Lolait SJ, Knepper MA. Oxytocin as an antidiuretic hormone. II. Role of V2 vasopressin receptor. Am J Physiol1995; 269: F78\u201385","DOI":"10.1152\/ajprenal.1995.269.1.F78"},{"key":"key\n\t\t\t\t20180110065227_R28","doi-asserted-by":"crossref","unstructured":"Schlein EM, Spooner GR, Day C, Pickering M, Cade R. Extrarenal water loss and antidiuretic hormone. J Appl Physiol1971; 31: 569\u2013572","DOI":"10.1152\/jappl.1971.31.4.569"},{"key":"key\n\t\t\t\t20180110065227_R29","unstructured":"Gaskill MB, Reilly M, Robertson GL. Vasopressin decreases insensible water loss. Clin Res1983; 31: 780A (Abstract)"},{"key":"key\n\t\t\t\t20180110065227_R30","doi-asserted-by":"crossref","unstructured":"Fay MJ, Du J, Yu X, North WG. Evidence for expression of vasopressin V2 receptor mRNA in human lung. Peptides1996; 17: 477\u2013481","DOI":"10.1016\/0196-9781(96)00009-5"},{"key":"key\n\t\t\t\t20180110065227_R31","unstructured":"Perks AM, Kindler PM, Marshall J, Woods B, Craddok C, Vonder\u2010Muhll I. Lung liquid production by in vitro lungs from fetal guinea pigs: effects of arginine vasopressin and arginine vasotocin. J Dev Physiol1993; 19: 203\u2013212"},{"key":"key\n\t\t\t\t20180110065227_R32","doi-asserted-by":"crossref","unstructured":"Hooper SB, Wallace MJ, Harding R. Amiloride blocks the inhibition of fetal lung liquid secretion caused by AVP but not asphyxia. J Appl Physiol1993; 74: 111\u2013115","DOI":"10.1152\/jappl.1993.74.1.111"},{"key":"key\n\t\t\t\t20180110065227_R33","doi-asserted-by":"crossref","unstructured":"Schafer JA, Hawk CT. Regulation of Na+ channels in the cortical collecting duct by AVP and mineralocorticoids. Kidney Int1992; 41: 255\u2013268","DOI":"10.1038\/ki.1992.37"},{"key":"key\n\t\t\t\t20180110065227_R34","unstructured":"Bankir L, Nicco C, Bouby N. Sustained stimulation of vasopressin V2 receptors in rats upregulates ENaC mRNA in the renal cortex. FASEB J2000; 14: A339 (abstract 276.2)"},{"key":"key\n\t\t\t\t20180110065227_R35","unstructured":"Bankir L, Nicco C, Wittner M, DiStefano A, Pajaud S, Bouby N. Sustained stimulation of vasopressin V2 receptors in rats strongly enhances the capacity of the collecting duct to reabsorb sodium and water. FASEB J2000; 14: A347 (abstract 277.23)"},{"key":"key\n\t\t\t\t20180110065227_R36","doi-asserted-by":"crossref","unstructured":"Martinez JR, Martinez AM. Effects of ADH and dibutyryl cyclic AMP on submaxillary secretion in the dog. Eur J Pharmacol1972; 18: 375\u2013385","DOI":"10.1016\/0014-2999(72)90039-8"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/16\/4\/725\/23369599\/160725.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T04:43:15Z","timestamp":1682224995000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/16\/4\/725\/1808803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,1]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2001,4]]},"published-print":{"date-parts":[[2001,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/16.4.725","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,4]]},"published":{"date-parts":[[2001,4,1]]}}}